#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Denmark Finland France Germany Italy +3

  • Study on Trastuzumab Emtansine, Pertuzumab, and Atezolizumab for Patients with HER2-Positive Metastatic Cancer Who Benefited from Previous Treatment

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium France Poland Portugal Spain

  • Study of Tislelizumab, Pamiparib, and Ociperlimab in Patients with Advanced Solid Tumors and Blood Cancers

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Poland

  • Study on the Safety and Effects of GEN1055 Alone and with Pembrolizumab for Patients with Malignant Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Spain

  • Study of Relatlimab, Nivolumab, and Drug Combination for Patients with Advanced Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Spain

  • Study on the Safety and Tolerability of Spartalizumab for Patients with Advanced Cancer

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    Belgium Czechia France Germany Hungary Italy +2

  • Study of AFM24 and Atezolizumab for Patients with Advanced or Metastatic EGFR-expressing Cancers

    Not recruiting

    1 1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland Spain

  • Study of BT5528 alone and with nivolumab in patients with advanced solid tumors that have EphA2 protein expression

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Spain

  • Study of Niraparib and Dostarlimab for Children with Recurrent or Hard-to-Treat Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Hungary Spain

  • Study of ALX148 and Pembrolizumab for Patients with Advanced Head and Neck Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium The Netherlands Spain